Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint
Esiloc was launched at the biggest doctor engagement webinar involving more than 12,000 doctors across the country
CGHS would give robust coverage to pensioners and with new innovations and practices
The acquisition of these two brands expands Lupin's portfolio of inhalation products in the U.S.
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Both the partners will work towards bringing Aster Pharmacy’s in-house quality care products to serve the healthcare needs of the local population in KSA
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
The symposium was organized to provide an opportunity to highlight the advances of aortic surgery and to discuss the future of aortic aneurysm management.
Periodic community awareness program through Aster’s DM Healthcare’s visual media and social media platforms and implementing TB control activity through Aster Pharmacies across South India
The Bulk Drug Park is expected to attract investment of around Rs. 10,000 crore and provide employment to more than 20,000 people
Subscribe To Our Newsletter & Stay Updated
